Medical Doctor Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Timothy Ryken

Neurological Surgery Des Moines, IA Medical Doctor

NPI 1235122359 CMS profile 9891

1215 Pleasant St Ste 608, Ste 280, Des Moines, IA 50309

Open in the dashboard

General payments

$43,777

72 records reported · program years 2019–2024

Research payments

$14,025

Paid to them · 7 records reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$11,420 paid to institutions, not to them · program years 2022–2023

Through program year 2024, Timothy Ryken of Des Moines, IA is reported in the CMS Open Payments database as having received $43,777 across 72 general payments and $14,025 in research payments paid to them. Separately, studies naming them as principal investigator received $11,420 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 87th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $9,737 19
2023 General $11,411 19
2022 General $17,414 27
2021 Research $1,050 2
2020 Research $1,575 2
2019 General $5,215 7
2019 Research $11,400 3

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Timothy Ryken
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Timothy Ryken were reported at $0. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Timothy Ryken Neurological Surgery median Middle half National median
2019 $5,215 $582 $138–$3,006 $163
2020 $0 $294 $76–$2,174 $114
2021 $0 $387 $105–$2,432 $132
2022 $17,414 $542 $139–$2,989 $149
2023 $11,411 $534 $145–$2,697 $160
2024 $9,737 $574 $155–$3,046 $164
2025 $0 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Medtronic, Inc. $37,273 59 payments
  2. DePuy Synthes Products, Inc. $4,095 1 payment
  3. Mighty Oak Medical $1,100 1 payment
  4. Arbor Pharmaceuticals, Inc. $998 2 payments
  5. GT Medical Technologies, Inc $108 2 payments
  6. DePuy Synthes Sales Inc. $89 2 payments
  7. Spineology Inc. $59 2 payments
  8. Synthes USA Products LLC $34 2 payments
  9. Nevro Corp. $22 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Consulting Fee $35,195 5 payments
  2. Travel and Lodging $3,632 23 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $2,250 1 payment
  4. Food and Beverage $1,702 41 payments
  5. Education $998 2 payments
Products named General payments · program years 2019–2024
  1. MIDAS REX $33,156 30 payments
  2. VIPER $4,170 2 payments
  3. EXPEDIUM $4,095 1 payment
  4. BRAINLAB $4,095 1 payment
  5. MOUNTAINEER $4,095 1 payment
  6. ENDOSKELETON TC NANOLOCK SURFACE TECHNOLOGY $2,250 1 payment
  7. Gliadel $998 2 payments
  8. MAZOR X SYSTEM $619 6 payments
  9. UNID_PASS $164 1 payment
  10. ADAPTIX INTERBODY SYSTEM WITH TITAN NANOLOCK SURFACE TECHNOLOGY $125 1 payment
  11. Other $408 16 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2024
  1. Arbor Pharmaceuticals, Inc. $14,025 7 payments

Billing to Medicare

Part B · data year 2024 · 31 billing codes

Paid by Medicare

$33,031

Medicare's payments for the services billed

Medicare patients

52

Average age 75

Services billed

115

25 women, 27 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 67%
Arthritis 56%
Atrial fibrillation 33%
Depression 29%
Heart failure 25%
Chronic kidney disease 25%
COPD 25%
Diabetes 23%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

79 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record